Profile
Jacques Dumas served as the Chief Scientific Officer & Executive VP at AstraZeneca PLC from 2010 to 2014.
Prior to that, he held the same position at Idenix Pharmaceuticals LLC.
He also served as the Chief Scientific Officer at Tetraphase Pharmaceuticals, Inc. from 2015 to 2019.
Before his industry roles, Dumas earned a doctorate degree from Université Pierre et Marie Curie in 1991.
Former positions of Jacques Dumas
| Companies | Position | End |
|---|---|---|
| TETRAPHASE PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/07/2019 |
| ASTRAZENECA PLC | Chief Tech/Sci/R&D Officer | 01/01/2014 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | - |
| IDENIX PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | - |
Training of Jacques Dumas
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
Université Pierre et Marie Curie
Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
- Stock Market
- Insiders
- Jacques Dumas
















